Market Overview:
The global isothermal nucleic acid amplification technology (INAAT) market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for rapid and accurate diagnostics, rising prevalence of infectious diseases, and growing awareness about cancer screening. The INAAT market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into instruments and reagents. The instruments segment accounted for a larger share in 2017 owing to its growing demand for point-of-care testing (POCT). On the basis of application, the market is divided into blood screening, infectious disease diagnostics, cancer diagnosis & treatment research laboratories), and others (prenatal diagnosis & genetic testing). In 2017, blood screening was estimated as one among top three applications with highest revenue share in this sector followed by infectious disease diagnostics due to increase in number outbreaks caused by various pathogens across globe .Geographically ,the global INAATmarketis classifiedinto five regions: North America , Latin America Europe Asia Pacificand Middle East& Africa .
 Industry Outlook.svg)
Product Definition:
Isothermal Nucleic Acid Amplification Technology (INAAT) is a technology used to amplify nucleic acids. It is important because it can be used to detect and diagnose diseases.
Instrument:
Instrument is used for the purpose of performing INAAT. It’s a device or a kit that helps in increasing the efficiency of amplification process. There are different types of instruments available in the market, which are used for various applications such as molecular diagnostics, forensics and genetic testing etc. Some common instruments used for INAAT include PCR (polymerase chain reaction) system, thermal cycler and DNA analyzer among others.
Reagent:
Reagents are chemicals that help in the amplification process of DNA or RNA. There are two types of reagents namely, those used for thermal and isothermal amplification. The most commonly used reagent is Polymerase Chain Reaction (PCR) based reagent which helps in amplifying a specific region of an DNA or RNA molecule.
Application Insights:
The global isothermal nucleic acid amplification technology market has been classified into five segments based on application as infectious disease diagnostics, cancer, other diseases, blood screening and others. The other segment includes genetic testing and prenatal diagnosis. The infectious disease diagnostics segment held the largest share in 2017 owing to the growing prevalence of chronic diseases such as HIV/AIDS and tuberculosis across the globe.
Blood screening is anticipated to be one of the fastest-growing segments during forecast years due to high demand for rapid diagnostic tests for various blood disorders such as hemophilia and leukemia with low costs involved inNAAT procedures. Furthermore, introduction of advanced products with enhanced performance is expected to boost growth during this period. For instance, Inneov AG announced about entering into a partnership deal with Qiagen Ltd., under which both companies will develop automated NAAT systems that will enable faster throughput while reducing cost in sample preparation for large-scale clinical trials applications within three years from 2018 onward.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure, and high adoption rate for technologically advanced products are some of the factors responsible for its large share. Moreover, increasing government funding to INAAT-based research is also expected to contribute towards regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income and growing target population base in countries such as India & China & Australia.
Growth Factors:
- Increasing demand for nucleic acid amplification technology in the field of molecular diagnostics
- Rising prevalence of infectious diseases and genetic disorders
- Growing number of private and public diagnostic laboratories
- Technological advancements in INAAT devices and kits
- Increasing awareness about advanced diagnostic techniques
Scope Of The Report
Report Attributes
Report Details
Report Title
Isothermal Nucleic Acid Amplification Technology (INAAT) Market Research Report
By Type
Instrument, Reagent
By Application
Blood screening, Infectious disease diagnostics, Cancer, Others
By Companies
Alere, bioMerieux, Chemical, Hologic, Lucigen, QIAGEN, Quidel Corporation, Thermo Fisher Scientific, BD
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Report Segments:
The global Isothermal Nucleic Acid Amplification Technology (INAAT) market is segmented on the basis of:
Types
Instrument, Reagent
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Blood screening, Infectious disease diagnostics, Cancer, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Alere
- bioMerieux
- Chemical
- Hologic
- Lucigen
- QIAGEN
- Quidel Corporation
- Thermo Fisher Scientific
- BD
 Market Overview.svg)
Highlights of The Isothermal Nucleic Acid Amplification Technology (INAAT) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Instrument
- Reagent
- By Application:
- Blood screening
- Infectious disease diagnostics
- Cancer
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Isothermal Nucleic Acid Amplification Technology (INAAT) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
INAAT is a technology that amplifies nucleic acids using isothermal methods. This technology allows for the rapid and efficient amplification of target DNA or RNA sequences.
Some of the major players in the isothermal nucleic acid amplification technology (inaat) market are Alere, bioMerieux, Chemical, Hologic, Lucigen, QIAGEN, Quidel Corporation, Thermo Fisher Scientific, BD.
The isothermal nucleic acid amplification technology (inaat) market is expected to grow at a compound annual growth rate of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Isothermal Nucleic Acid Amplification Technology (INAAT) Market - Supply Chain
4.5. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Forecast
4.5.1. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Absolute $ Opportunity
5. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Volume Forecast by Type
5.3.1. Instrument
5.3.2. Reagent
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Volume Forecast by Application
6.3.1. Blood screening
6.3.2. Infectious disease diagnostics
6.3.3. Cancer
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Demand Share Forecast, 2019-2029
9. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Volume Forecast by Application
9.4.1. Blood screening
9.4.2. Infectious disease diagnostics
9.4.3. Cancer
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Volume Forecast by Type
9.7.1. Instrument
9.7.2. Reagent
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Demand Share Forecast, 2019-2029
10. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Volume Forecast by Application
10.4.1. Blood screening
10.4.2. Infectious disease diagnostics
10.4.3. Cancer
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Volume Forecast by Type
10.7.1. Instrument
10.7.2. Reagent
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Demand Share Forecast, 2019-2029
11. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Volume Forecast by Application
11.4.1. Blood screening
11.4.2. Infectious disease diagnostics
11.4.3. Cancer
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis byApplication
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Volume Forecast by Type
11.7.1. Instrument
11.7.2. Reagent
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Demand Share, 2019-2029
12. Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Volume Forecast by Application
12.4.1. Blood screening
12.4.2. Infectious disease diagnostics
12.4.3. Cancer
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Volume Forecast by Type
12.7.1. Instrument
12.7.2. Reagent
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Demand Share, 2019-2029
13. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Volume Forecast by Application
13.4.1. Blood screening
13.4.2. Infectious disease diagnostics
13.4.3. Cancer
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Volume Forecast by Type
13.7.1. Instrument
13.7.2. Reagent
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Market Share Analysis
14.2. Isothermal Nucleic Acid Amplification Technology (INAAT) Distributors and Customers
14.3. Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Alere
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. bioMerieux
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Chemical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Hologic
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Lucigen
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. QIAGEN
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Quidel Corporation
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Thermo Fisher Scientific
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. BD
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
